Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Adjusted Non-GAAP SG&A Expense by Year
Adjusted Non-GAAP SG&A Expense ($M) ($M)
Stryker Adjusted Non-GAAP SG&A Expense: $8,221M in FY2025, up 10.6% from a year earlier.
Latest, FY2025
8,221
Period ended Dec 31, 2025
Change on a year earlier
+10.6%
7,436 in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Where the FY2025 figure comes from
Reported in Stryker Form 8-K Non-GAAP Schedules.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted Non-GAAP SG&A Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,221 | +10.6% | 0000310764-26-000006|sykex991earningsq42025.htm ↗ |
| FY2024 | Dec 31, 2024 | 7,436 | +8.5% | 0000310764-25-000005|sykex991earningsq42024.htm ↗ |
| FY2023 | Dec 31, 2023 | 6,851 | – | 0000310764-24-000005|sykex991earningsq42023.htm ↗ |
Cite this data
StockData. (2026). Stryker Adjusted Non-GAAP SG&A Expense ($M), annual FY2023–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-sga-m
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.